ICD-10 Coding for Cervical Intraepithelial Neoplasia III(D06.9)
Complete ICD-10-CM coding and documentation guide for Cervical Intraepithelial Neoplasia III. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Cervical Intraepithelial Neoplasia III
D06.0-D06.9Primary Range
Carcinoma in situ of cervix uteri
This range includes all site-specific codes for CIN III, which is classified as carcinoma in situ.
Dysplasia of cervix uteri
This range includes codes for cervical dysplasia, which are used for lower grades than CIN III.
Key Information: ICD-10 code for cervical intraepithelial neoplasia III
Essential facts and insights about Cervical Intraepithelial Neoplasia III
Primary ICD-10-CM Code for cervical intraepithelial neoplasia roman numeral for the number 3
Decision Criteria
clinical Criteria
- Histological confirmation of CIN III
coding Criteria
- Use D06.9 for unspecified site of CIN III
Clinical Validation Requirements
- Histology report confirming CIN III
- p16 immunohistochemistry positivity
Code-Specific Risks
- Misclassification of CIN II as CIN III without p16 confirmation
Coding Notes
- Ensure histological confirmation and p16 positivity for CIN III coding.
Ancillary Codes
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Abnormal cytologic findings on cervical screening
R87.611Differential Codes
Alternative codes to consider when ruling out similar conditions to the primary diagnosis.
Moderate dysplasia of cervix uteri
N87.1Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Cervical Intraepithelial Neoplasia III to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code D06.9.
Impact
Clinical: May lead to inappropriate treatment planning., Regulatory: Non-compliance with documentation standards., Financial: Potential claim denials due to lack of specificity.
Mitigation Strategy
Use specific CIN terminology., Verify histological findings.
Impact
Reimbursement: Incorrect coding may lead to claim denials., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data reporting.
Mitigation Strategy
Ensure p16 positivity and explicit CIN III confirmation before coding.
Impact
Coding CIN III without histological confirmation.
Mitigation Strategy
Require biopsy and p16 results before coding.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Cervical Intraepithelial Neoplasia III, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Cervical Intraepithelial Neoplasia III
Use these documentation templates to ensure complete and accurate documentation for Cervical Intraepithelial Neoplasia III. These templates include all required elements for proper coding and billing.
CIN III confirmed by biopsy
Specialty: GynecologyRequired Elements
- Patient demographics
- Biopsy results
- p16 immunohistochemistry
- Treatment plan
Example Documentation
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Cervical Intraepithelial Neoplasia III? Ask your questions below.